Finance

Lists
600420:SHA
Shanghai Shyndec Pharmaceutical Co Ltd
CN¥8.33
-0.83%
(-0.070) 1D
Oct 16, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600420...
Open
CN¥8.40
High
CN¥8.53
Low
CN¥8.25
Mkt. cap
11.17B
Avg. vol.
6.03M
Volume
7.61M
Dividend
3.00%
Quarterly dividend
CN¥0.06
Ex-dividend date
Sep 18, 2026
P/E ratio
20.49
52-wk high
CN¥11.09
52-wk low
CN¥7.67
EPS
CN¥0.41
Shares outstanding
1.06B
No. of employees
10K
Open
CN¥8.40
High
CN¥8.53
Low
CN¥8.25
Mkt. cap
11.17B
Avg. vol.
6.03M
Volume
7.61M
Dividend
3.00%
Quarterly dividend
CN¥0.06
Ex-dividend date
Sep 18, 2026
P/E ratio
20.49
52-wk high
CN¥11.09
52-wk low
CN¥7.67
EPS
CN¥0.41
Shares outstanding
1.06B
No. of employees
10K
News stories
From web sources and news partners
About Shanghai Shyndec Pharmaceutical Co Ltd
CEO-
Employees9.7K
FoundedNov 27, 1996
Headquarters-
SectorPharmaceutical industry
Websiteshyndec.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.04B
2.44B
2.06B
1.88B
Cost of goods sold
1.45B
1.82B
1.44B
1.36B
Cost of revenue
1.45B
1.82B
1.44B
1.36B
Research and development expenses
103.68M
105.95M
78.82M
87.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
274.94M
399.48M
278.47M
278.02M
Operating expense
372.50M
563.58M
374.72M
377.27M
Total operating expenses
1.83B
2.38B
1.82B
1.74B
Operating income
216.71M
57.91M
248.68M
136.68M
Other non operating income
25.76M
-20.75M
-12.37M
9.92M
EBT including unusual items
190.56M
212.10M
248.32M
194.78M
EBT excluding unusual items
267.61M
111.77M
270.29M
146.61M
Income tax expense
27.51M
3.16M
56.18M
23.69M
Effective tax rate
14.44%
1.49%
22.62%
12.16%
Other operating expenses
-8.58M
59.46M
8.61M
13.63M
Net income
129.10M
140.43M
138.40M
137.19M
Net profit margin
6.32%
5.75%
6.70%
7.31%
Earnings per share
-
-
-
-
Interest and investment income
37.46M
72.55M
34.52M
24.50M
Interest expense
-1.32M
-223.56K
-538.23K
-490.94K
Net interest expenses
36.14M
72.32M
33.98M
24.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
404.71M
232.56M
423.32M
315.65M
Gain or loss from assets sale
-65.42K
2.65M
-
557.24K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps